Market Segments

BGG World Appoints Shaheen Majeed as CEO

Majeed will fill in the role upon the retirement of current CEO Bob Cappelli.

01.17.22

Vitamin K Status May Have Stronger Impact on COVID-19 Than Vitamin D Deficiency

A new study supported by Kappa Bioscience concludes that D supplementation should be complemented with vitamin D.

01.17.22

Lycored Opens New Processing Facility in New Jersey

The site also features an application lab and color production line for localized flavor and color development.

01.17.22

Green Mediterranean Diet Linked to Better Cognitive Health Outcomes

The closer patients adhered to a high-polyphenol diet mostly containing plants, the more optimal their brain measurements were, researchers concluded.

01.17.22

Phynova, InVita Reach Distribution Agreement for Reducose Sales in Eastern Europe/Asia

InVita will sell the white mulberry leaf extract to customers in Russia, Kazakhstan, Belarus, and Armenia.

01.17.22

Aker BioMarine Appoints Simon Seward as Human Health and Nutrition EVP

Seward, an expert in global nutrition and aquaculture markets, will oversee the expansion of the Superba brand of krill oil.

01.17.22

Kerry Releases Global, Regional Taste Charts for 2022

The flavor and nutrition company shared key consumer shifts that will shape food and beverage innovation and product launches in 2022.

01.13.22

PEA as a CBD Alternative? Analysis Breaks Down the Overlap and Differences

While there is much to uncover in the realm of human outcomes, the paper makes an in-depth scientific comparison between the two endocannabinoids.

01.13.22

Two Cannabis Compounds Inhibit COVID-19 Infection in In Vitro Study

CBDA and CBGA bind to the SARS-CoV-2 spike protein, according to a team of Oregon State University researchers.

01.13.22

Olam Food Ingredients Partners with Brightseed to Use its AI Research Platform

The goal of the partnership will be to identify novel health benefits and compounds in black pepper and garlic, two extensively researched botanicals.

01.13.22

Gadot Encouraged by FDA’s Qualified Health Claims Approval for Magnesium

CEO Ohad Cohen said that the agency’s decision will allow this health benefit to be much more well-understood across both the industry and consumers.

01.13.22

Probiotic Formula Shown to Benefit COVID-19 Outpatients with Mild Symptoms

Kaneka Group/AB-Biotics' AB21 was associated with reduction of viral load, duration of symptoms, and rate of remission in a study conducted in 2020.

01.12.22

Cancer Survivors with Adequate Nutrition had Self-Reported Higher Quality of Life

Based on NHANES data collected from cancer survivors, the authors of a review found that the use of supplements was linked to long-term, cost-effective benefit.

01.11.22

Liz Richardson and Steve Mister Elected as DSQC Steering Committee Chair and Vice Chair

Under their leadership, DSQC will continue to advocate for mandatory product listings, and strengthening FDA’s regulatory capacities.

01.11.22

Pharmactive Certifies Sustainability Program to ISO Standards

The ramped-up sustainability policy is honing in on emphasizing fair trade, local women’s workforces, and reductions in waste and energy consumption.

01.11.22

Breaking News | Cardiovascular Health | Research | Research News

Olive Oil Intake Associated with Lower Risk of Cardiovascular Disease Mortality

Study also finds benefit for swapping margarine, butter, mayonnaise, and dairy fat with olive oil.

01.11.22

Breaking News | Functional Foods & Beverages | Products | Proteins, Peptides, Amino Acids

Plant-Based Salmon Burgers Hit Market with 16 Grams of Protein Per Serving

Gathered Foods product will be available through a partnership with UNFI and sold online.

01.11.22

Annatto Tocotrienol Modifies Metabolism for Favorable Oxidative, Inflammatory Responses

The potent form of vitamin E modified over 100 metabolites related to oxidative stress and inflammation in postmenopausal women.

01.10.22

Magnesium Receives Qualified Health Claim on Blood Pressure Reduction from FDA

Following a review of the evidence, FDA now supports three types of claims on the research, which it still considers to be “inconsistent and inconclusive.”

01.10.22